Pharmaceuticals - Community Register


Community register of orphan medicinal products


Product information


EU orphan designation number: EU/3/01/028   
Active ingredient: Inolimomab
Indication: Treatment of Graft versus Host Disease
Sponsor: EUSA Pharma SAS
3 allée des Séquoias, F-69760 Limonest, France

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
08/03/2001 Orphan designation EMEA/OD/038/00 (2001)488 of 05/03/2001
20/07/2004 Change of name and/or address of sponsor
22/01/2008 Change of name and/or address of sponsor